ARDS and other Type I Respiratory Failure (100 mmHg ≤ PaO2/FiO2 < 300 mmHg)
Type II Respiratory Failure
Invasive Ventilation Weanin
Fight the epidemic together:
Novel Coronavirus Pneumonia (NCP) is a pneumonia caused by SARS- CoV- 2 infection.
Severe and critically ill patients often have hypoxemia and dyspnea and proper respiratory support treatment is required.
As noted in the “Expert Consensus on the Use and Management of HFNC for Patients with Novel Coronavirus Pneumonia”, for acute hypoxic respiratory failure, high-flow nasal O2 therapy (HFNC) has greater advantages over conventional O2 therapy.
Simple and practical Ultra-Large touch screen: NF5 is equipped with a 4.3- inch touch screen, which allows easy and quick operation by touch and navigation knob.
Electronic Air- O2 mixer system: easy to set up flow rate and O2 concentration. Intuitive
UI design: large font, easy for caregiver to operate and observe
SpO2 Monitoring: Optional Comen, Masimo or Nellcor SpO2 monitoring function, real- time monitoring of the patient's O2 concentration, ease evaluation of the effectiveness of high- flow O2 therapy, so that doctors can optimize the treatment plan in real time.
Intra- hospital transport High performance turbine, no need for compressed air supply
Integrated battery for transportation Light and compact medical trolley ease intra- hospital transport.
Wide range of application: The 2- 80L/min wide range flow control can effectively flush the dead space (physiology), avoid CO2 retention, meet the treatment requirement of both infants and adults, clinically suitable for patients at different ages.